Conversion of Tuberculosis Screening Tests During Biologic Therapy Among Veteran Patient Population With Rheumatic Disease

OBJECTIVE: The optimal strategy to detect the development of tuberculosis (TB) in subjects receiving biologic agents is not clear. The recommendations vary because there is wide variation in the reported rate of seroconversion in various parts of the world. There is a scarcity of long‐term studies r...

Descripción completa

Detalles Bibliográficos
Autores principales: Pattanaik, Debendra, Gupta, Sandeep, Islam, Syed, Singhal, Kunal, Raza, Syed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857984/
https://www.ncbi.nlm.nih.gov/pubmed/31777837
http://dx.doi.org/10.1002/acr2.11070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857984/
https://www.ncbi.nlm.nih.gov/pubmed/31777837
http://dx.doi.org/10.1002/acr2.11070

Ejemplares similares